Teleflex, a global provider of medical devices for critical care and surgery, has announced the US Food and Drug Administration’s (FDA) 510(k) clearance for restated Indications for use of the EZ-IO® vascular access system.
The EZ-IO 25mm needle set is now indicated for patients 3kg or over. Teleflex recently announced its acquisition of Vidacare, developer of the EZ-IO vascular access system.
Teleflex Vascular Access division president and general manager Jay White noted as part of the company’s fight for zero complications in vascular access, it has committed to continuously improving its technologies, enhancing the company’s training and educational initiatives, and partnering with healthcare professionals to provide innovative solutions for treating difficult vascular access patients with the EZ-IO vascular access system.
"We’re excited about the restated indications for use, because we’ve made it even easier for clinicians to select the right needle for their patient," White added.